AU5593300A - Modulation of gene expression in gastrointestinal inflammation - Google Patents

Modulation of gene expression in gastrointestinal inflammation Download PDF

Info

Publication number: AU5593300A
Authority: AU; Australia
Prior art keywords: seq; polypeptide; polynucleotide; sequence; antibody
Prior art date: 1999-06-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU55933/00A

Other languages

English (en)

Inventor

Robert Finley Dubose

Karl W Hasel

Brian S. Hilbush

Thomas M. Pribyl

John E. Sims

Adel Youakim

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Digital Gene Technologies Inc

Original Assignee

Digital Gene Technologies Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-01

Filing date

2000-06-01

Publication date

2000-12-18

2000-06-01 Application filed by Digital Gene Technologies Inc filed Critical Digital Gene Technologies Inc

2000-12-18 Publication of AU5593300A publication Critical patent/AU5593300A/en

Status Abandoned legal-status Critical Current

Links

230000014509 gene expression Effects 0.000 title claims description 37
206010064147 Gastrointestinal inflammation Diseases 0.000 title claims description 7
108090000765 processed proteins & peptides Proteins 0.000 claims description 294
229920001184 polypeptide Polymers 0.000 claims description 287
102000004196 processed proteins & peptides Human genes 0.000 claims description 287
108091033319 polynucleotide Proteins 0.000 claims description 153
102000040430 polynucleotide Human genes 0.000 claims description 153
239000002157 polynucleotide Substances 0.000 claims description 152
238000000034 method Methods 0.000 claims description 110
108090000623 proteins and genes Proteins 0.000 claims description 110
239000002773 nucleotide Substances 0.000 claims description 103
125000003729 nucleotide group Chemical group 0.000 claims description 103
102000004169 proteins and genes Human genes 0.000 claims description 70
150000007523 nucleic acids Chemical class 0.000 claims description 61
102000039446 nucleic acids Human genes 0.000 claims description 59
108020004707 nucleic acids Proteins 0.000 claims description 59
239000012634 fragment Substances 0.000 claims description 58
150000001413 amino acids Chemical class 0.000 claims description 50
230000000694 effects Effects 0.000 claims description 45
239000002299 complementary DNA Substances 0.000 claims description 41
108020004414 DNA Proteins 0.000 claims description 37
239000000523 sample Substances 0.000 claims description 37
238000009739 binding Methods 0.000 claims description 33
230000027455 binding Effects 0.000 claims description 32
239000013598 vector Substances 0.000 claims description 28
238000003556 assay Methods 0.000 claims description 21
230000004071 biological effect Effects 0.000 claims description 19
108010074328 Interferon-gamma Proteins 0.000 claims description 17
150000001875 compounds Chemical class 0.000 claims description 17
102000008070 Interferon-gamma Human genes 0.000 claims description 15
229960003130 interferon gamma Drugs 0.000 claims description 15
238000004519 manufacturing process Methods 0.000 claims description 14
239000012472 biological sample Substances 0.000 claims description 13
230000001575 pathological effect Effects 0.000 claims description 11
230000035772 mutation Effects 0.000 claims description 10
238000012217 deletion Methods 0.000 claims description 9
230000037430 deletion Effects 0.000 claims description 9
102000004190 Enzymes Human genes 0.000 claims description 8
108090000790 Enzymes Proteins 0.000 claims description 8
230000001105 regulatory effect Effects 0.000 claims description 8
238000012360 testing method Methods 0.000 claims description 8
239000002253 acid Substances 0.000 claims description 7
102000053602 DNA Human genes 0.000 claims description 6
230000036961 partial effect Effects 0.000 claims description 6
230000033228 biological regulation Effects 0.000 claims description 4
239000005022 packaging material Substances 0.000 claims description 4
238000004166 bioassay Methods 0.000 claims description 3
238000012258 culturing Methods 0.000 claims description 3
229910052751 metal Inorganic materials 0.000 claims description 2
239000002184 metal Substances 0.000 claims description 2
150000002739 metals Chemical class 0.000 claims description 2
210000004027 cell Anatomy 0.000 description 93
238000003752 polymerase chain reaction Methods 0.000 description 87
235000018102 proteins Nutrition 0.000 description 64
235000001014 amino acid Nutrition 0.000 description 60
125000003275 alpha amino acid group Chemical group 0.000 description 57
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 48
239000000047 product Substances 0.000 description 48
210000001519 tissue Anatomy 0.000 description 31
239000003153 chemical reaction reagent Substances 0.000 description 29
241000282414 Homo sapiens Species 0.000 description 26
201000010099 disease Diseases 0.000 description 24
208000035475 disorder Diseases 0.000 description 24
108020004999 messenger RNA Proteins 0.000 description 24
108091032973 (ribonucleotides)n+m Proteins 0.000 description 19
238000006243 chemical reaction Methods 0.000 description 18
108091028043 Nucleic acid sequence Proteins 0.000 description 17
230000004888 barrier function Effects 0.000 description 17
230000028993 immune response Effects 0.000 description 17
241001465754 Metazoa Species 0.000 description 16
241000894007 species Species 0.000 description 16
238000011282 treatment Methods 0.000 description 16
238000004458 analytical method Methods 0.000 description 15
210000000349 chromosome Anatomy 0.000 description 15
239000000427 antigen Substances 0.000 description 14
230000001965 increasing effect Effects 0.000 description 14
239000000203 mixture Substances 0.000 description 14
238000006467 substitution reaction Methods 0.000 description 14
230000014616 translation Effects 0.000 description 14
238000009396 hybridization Methods 0.000 description 13
230000035755 proliferation Effects 0.000 description 13
238000013519 translation Methods 0.000 description 13
102100032249 Dystonin Human genes 0.000 description 12
108091007433 antigens Proteins 0.000 description 12
102000036639 antigens Human genes 0.000 description 12
230000015572 biosynthetic process Effects 0.000 description 12
230000015556 catabolic process Effects 0.000 description 12
239000003795 chemical substances by application Substances 0.000 description 12
108020001507 fusion proteins Proteins 0.000 description 12
102000037865 fusion proteins Human genes 0.000 description 12
230000007423 decrease Effects 0.000 description 11
230000003463 hyperproliferative effect Effects 0.000 description 11
101000821449 Homo sapiens Secreted and transmembrane protein 1 Proteins 0.000 description 10
125000000539 amino acid group Chemical group 0.000 description 10
239000002158 endotoxin Substances 0.000 description 10
208000015181 infectious disease Diseases 0.000 description 10
230000009870 specific binding Effects 0.000 description 10
208000022559 Inflammatory bowel disease Diseases 0.000 description 9
241000699666 Mus <mouse, genus> Species 0.000 description 9
241000699670 Mus sp. Species 0.000 description 9
108010076504 Protein Sorting Signals Proteins 0.000 description 9
238000005755 formation reaction Methods 0.000 description 9
230000002163 immunogen Effects 0.000 description 9
230000004048 modification Effects 0.000 description 9
238000012986 modification Methods 0.000 description 9
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 9
238000000746 purification Methods 0.000 description 9
208000024891 symptom Diseases 0.000 description 9
238000010200 validation analysis Methods 0.000 description 9
102000004127 Cytokines Human genes 0.000 description 8
108090000695 Cytokines Proteins 0.000 description 8
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
108091034117 Oligonucleotide Proteins 0.000 description 8
210000001744 T-lymphocyte Anatomy 0.000 description 8
230000000890 antigenic effect Effects 0.000 description 8
239000011230 binding agent Substances 0.000 description 8
210000004408 hybridoma Anatomy 0.000 description 8
238000001727 in vivo Methods 0.000 description 8
238000003757 reverse transcription PCR Methods 0.000 description 8
239000000758 substrate Substances 0.000 description 8
230000009261 transgenic effect Effects 0.000 description 8
206010028980 Neoplasm Diseases 0.000 description 7
102100021853 Secreted and transmembrane protein 1 Human genes 0.000 description 7
230000004075 alteration Effects 0.000 description 7
230000001580 bacterial effect Effects 0.000 description 7
230000003247 decreasing effect Effects 0.000 description 7
229940088598 enzyme Drugs 0.000 description 7
230000003053 immunization Effects 0.000 description 7
230000006698 induction Effects 0.000 description 7
239000003446 ligand Substances 0.000 description 7
239000003550 marker Substances 0.000 description 7
239000000463 material Substances 0.000 description 7
230000008569 process Effects 0.000 description 7
108020003175 receptors Proteins 0.000 description 7
102000005962 receptors Human genes 0.000 description 7
230000008929 regeneration Effects 0.000 description 7
238000011069 regeneration method Methods 0.000 description 7
239000007787 solid Substances 0.000 description 7
238000002560 therapeutic procedure Methods 0.000 description 7
238000002965 ELISA Methods 0.000 description 6
241000588724 Escherichia coli Species 0.000 description 6
241001529936 Murinae Species 0.000 description 6
108700026244 Open Reading Frames Proteins 0.000 description 6
206010052428 Wound Diseases 0.000 description 6
208000027418 Wounds and injury Diseases 0.000 description 6
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
230000000692 anti-sense effect Effects 0.000 description 6
210000001124 body fluid Anatomy 0.000 description 6
-1 cationic lipid Chemical class 0.000 description 6
230000003399 chemotactic effect Effects 0.000 description 6
230000035605 chemotaxis Effects 0.000 description 6
230000002759 chromosomal effect Effects 0.000 description 6
230000006378 damage Effects 0.000 description 6
230000004069 differentiation Effects 0.000 description 6
230000004927 fusion Effects 0.000 description 6
238000003384 imaging method Methods 0.000 description 6
210000002865 immune cell Anatomy 0.000 description 6
238000000338 in vitro Methods 0.000 description 6
238000002372 labelling Methods 0.000 description 6
230000001404 mediated effect Effects 0.000 description 6
210000000056 organ Anatomy 0.000 description 6
239000013612 plasmid Substances 0.000 description 6
206010061218 Inflammation Diseases 0.000 description 5
241000700605 Viruses Species 0.000 description 5
230000000903 blocking effect Effects 0.000 description 5
239000010839 body fluid Substances 0.000 description 5
230000000295 complement effect Effects 0.000 description 5
238000005516 engineering process Methods 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
239000000499 gel Substances 0.000 description 5
230000002068 genetic effect Effects 0.000 description 5
230000004054 inflammatory process Effects 0.000 description 5
238000013507 mapping Methods 0.000 description 5
239000011159 matrix material Substances 0.000 description 5
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 5
239000000243 solution Substances 0.000 description 5
208000023275 Autoimmune disease Diseases 0.000 description 4
108010015776 Glucose oxidase Proteins 0.000 description 4
239000004366 Glucose oxidase Substances 0.000 description 4
208000009329 Graft vs Host Disease Diseases 0.000 description 4
108010001336 Horseradish Peroxidase Proteins 0.000 description 4
108060003951 Immunoglobulin Proteins 0.000 description 4
102000008394 Immunoglobulin Fragments Human genes 0.000 description 4
108010021625 Immunoglobulin Fragments Proteins 0.000 description 4
102000012745 Immunoglobulin Subunits Human genes 0.000 description 4
108010079585 Immunoglobulin Subunits Proteins 0.000 description 4
241000124008 Mammalia Species 0.000 description 4
238000000636 Northern blotting Methods 0.000 description 4
239000004793 Polystyrene Substances 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
108010090804 Streptavidin Proteins 0.000 description 4
238000007792 addition Methods 0.000 description 4
239000011324 bead Substances 0.000 description 4
230000008901 benefit Effects 0.000 description 4
210000004899 c-terminal region Anatomy 0.000 description 4
229910052799 carbon Inorganic materials 0.000 description 4
230000007812 deficiency Effects 0.000 description 4
238000001514 detection method Methods 0.000 description 4
238000002405 diagnostic procedure Methods 0.000 description 4
210000001723 extracellular space Anatomy 0.000 description 4
229940116332 glucose oxidase Drugs 0.000 description 4
235000019420 glucose oxidase Nutrition 0.000 description 4
208000024908 graft versus host disease Diseases 0.000 description 4
238000002649 immunization Methods 0.000 description 4
102000018358 immunoglobulin Human genes 0.000 description 4
208000014674 injury Diseases 0.000 description 4
210000005026 intestinal epithelial barrier Anatomy 0.000 description 4
150000002632 lipids Chemical class 0.000 description 4
210000001165 lymph node Anatomy 0.000 description 4
229930182817 methionine Natural products 0.000 description 4
229920002223 polystyrene Polymers 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
238000012545 processing Methods 0.000 description 4
238000007894 restriction fragment length polymorphism technique Methods 0.000 description 4
238000012216 screening Methods 0.000 description 4
238000012163 sequencing technique Methods 0.000 description 4
210000003491 skin Anatomy 0.000 description 4
210000004989 spleen cell Anatomy 0.000 description 4
230000008733 trauma Effects 0.000 description 4
WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 3
208000030507 AIDS Diseases 0.000 description 3
241000972773 Aulopiformes Species 0.000 description 3
241000894006 Bacteria Species 0.000 description 3
108020004705 Codon Proteins 0.000 description 3
208000035473 Communicable disease Diseases 0.000 description 3
108020004635 Complementary DNA Proteins 0.000 description 3
208000001860 Eye Infections Diseases 0.000 description 3
238000005481 NMR spectroscopy Methods 0.000 description 3
208000001388 Opportunistic Infections Diseases 0.000 description 3
206010035664 Pneumonia Diseases 0.000 description 3
206010040070 Septic Shock Diseases 0.000 description 3
238000012300 Sequence Analysis Methods 0.000 description 3
206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 3
230000003321 amplification Effects 0.000 description 3
239000005557 antagonist Substances 0.000 description 3
230000001363 autoimmune Effects 0.000 description 3
239000000872 buffer Substances 0.000 description 3
230000008859 change Effects 0.000 description 3
238000003776 cleavage reaction Methods 0.000 description 3
125000004122 cyclic group Chemical group 0.000 description 3
238000001962 electrophoresis Methods 0.000 description 3
230000004890 epithelial barrier function Effects 0.000 description 3
210000003527 eukaryotic cell Anatomy 0.000 description 3
208000011323 eye infectious disease Diseases 0.000 description 3
238000009472 formulation Methods 0.000 description 3
230000002538 fungal effect Effects 0.000 description 3
230000003394 haemopoietic effect Effects 0.000 description 3
210000003958 hematopoietic stem cell Anatomy 0.000 description 3
230000002439 hemostatic effect Effects 0.000 description 3
102000047454 human SECTM1 Human genes 0.000 description 3
239000012678 infectious agent Substances 0.000 description 3
230000000977 initiatory effect Effects 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
230000003993 interaction Effects 0.000 description 3
210000003041 ligament Anatomy 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
239000012528 membrane Substances 0.000 description 3
238000010172 mouse model Methods 0.000 description 3
210000000440 neutrophil Anatomy 0.000 description 3
238000003199 nucleic acid amplification method Methods 0.000 description 3
230000005298 paramagnetic effect Effects 0.000 description 3
230000004853 protein function Effects 0.000 description 3
230000002285 radioactive effect Effects 0.000 description 3
238000010188 recombinant method Methods 0.000 description 3
238000011084 recovery Methods 0.000 description 3
230000004044 response Effects 0.000 description 3
108091008146 restriction endonucleases Proteins 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
230000001177 retroviral effect Effects 0.000 description 3
235000019515 salmon Nutrition 0.000 description 3
230000007017 scission Effects 0.000 description 3
238000003860 storage Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
210000002435 tendon Anatomy 0.000 description 3
230000002537 thrombolytic effect Effects 0.000 description 3
238000001890 transfection Methods 0.000 description 3
238000011830 transgenic mouse model Methods 0.000 description 3
230000003612 virological effect Effects 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
BAAVRTJSLCSMNM-CMOCDZPBSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]pentanedioic acid Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 BAAVRTJSLCSMNM-CMOCDZPBSA-N 0.000 description 2
OBYNJKLOYWCXEP-UHFFFAOYSA-N 2-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]-4-isothiocyanatobenzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(N=C=S)=CC=C1C([O-])=O OBYNJKLOYWCXEP-UHFFFAOYSA-N 0.000 description 2
BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 2
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
108020005544 Antisense RNA Proteins 0.000 description 2
101100230428 Caenorhabditis elegans hil-5 gene Proteins 0.000 description 2
206010010741 Conjunctivitis Diseases 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
238000009007 Diagnostic Kit Methods 0.000 description 2
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
108091060211 Expressed sequence tag Proteins 0.000 description 2
206010018612 Gonorrhoea Diseases 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
108010093488 His-His-His-His-His-His Proteins 0.000 description 2
241000282412 Homo Species 0.000 description 2
101000975472 Homo sapiens Keratin, type I cytoskeletal 12 Proteins 0.000 description 2
108090000144 Human Proteins Proteins 0.000 description 2
102000003839 Human Proteins Human genes 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
206010020751 Hypersensitivity Diseases 0.000 description 2
108700005091 Immunoglobulin Genes Proteins 0.000 description 2
102100037850 Interferon gamma Human genes 0.000 description 2
101150040736 K12 gene Proteins 0.000 description 2
208000016604 Lyme disease Diseases 0.000 description 2
201000009906 Meningitis Diseases 0.000 description 2
241000699660 Mus musculus Species 0.000 description 2
206010035226 Plasma cell myeloma Diseases 0.000 description 2
206010037549 Purpura Diseases 0.000 description 2
241001672981 Purpura Species 0.000 description 2
108091034057 RNA (poly(A)) Proteins 0.000 description 2
208000033464 Reiter syndrome Diseases 0.000 description 2
206010063837 Reperfusion injury Diseases 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
208000019802 Sexually transmitted disease Diseases 0.000 description 2
238000002105 Southern blotting Methods 0.000 description 2
108091081024 Start codon Proteins 0.000 description 2
208000006011 Stroke Diseases 0.000 description 2
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 2
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 2
230000006052 T cell proliferation Effects 0.000 description 2
201000005485 Toxoplasmosis Diseases 0.000 description 2
208000025865 Ulcer Diseases 0.000 description 2
WCDYMMVGBZNUGB-ORPFKJIMSA-N [(2r,3r,4s,5r,6r)-6-[[(1r,3r,4r,5r,6r)-4,5-dihydroxy-2,7-dioxabicyclo[4.2.0]octan-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3-hydroxy-2-tetradecyloctadecanoate Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](COC(=O)C(CCCCCCCCCCCCCC)C(O)CCCCCCCCCCCCCCC)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H]2OC[C@H]2O1 WCDYMMVGBZNUGB-ORPFKJIMSA-N 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
230000002776 aggregation Effects 0.000 description 2
238000004220 aggregation Methods 0.000 description 2
239000000556 agonist Substances 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
210000003719 b-lymphocyte Anatomy 0.000 description 2
210000004082 barrier epithelial cell Anatomy 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004204 blood vessel Anatomy 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
210000005013 brain tissue Anatomy 0.000 description 2
239000011575 calcium Substances 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
208000015114 central nervous system disease Diseases 0.000 description 2
238000002512 chemotherapy Methods 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
230000035602 clotting Effects 0.000 description 2
230000000112 colonic effect Effects 0.000 description 2
239000003184 complementary RNA Substances 0.000 description 2
238000004590 computer program Methods 0.000 description 2
238000002316 cosmetic surgery Methods 0.000 description 2
230000002950 deficient Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
229960002086 dextran Drugs 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
230000003828 downregulation Effects 0.000 description 2
239000003814 drug Substances 0.000 description 2
239000000975 dye Substances 0.000 description 2
208000001848 dysentery Diseases 0.000 description 2
230000002124 endocrine Effects 0.000 description 2
230000002346 endotoxic effect Effects 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
230000001747 exhibiting effect Effects 0.000 description 2
238000010195 expression analysis Methods 0.000 description 2
210000002950 fibroblast Anatomy 0.000 description 2
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
238000001215 fluorescent labelling Methods 0.000 description 2
230000006870 function Effects 0.000 description 2
230000005251 gamma ray Effects 0.000 description 2
210000001035 gastrointestinal tract Anatomy 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
230000009395 genetic defect Effects 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
201000006592 giardiasis Diseases 0.000 description 2
239000011521 glass Substances 0.000 description 2
238000002873 global sequence alignment Methods 0.000 description 2
208000001786 gonorrhea Diseases 0.000 description 2
230000012010 growth Effects 0.000 description 2
208000006454 hepatitis Diseases 0.000 description 2
231100000283 hepatitis Toxicity 0.000 description 2
238000004128 high performance liquid chromatography Methods 0.000 description 2
210000003917 human chromosome Anatomy 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
208000009326 ileitis Diseases 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
208000026278 immune system disease Diseases 0.000 description 2
238000010185 immunofluorescence analysis Methods 0.000 description 2
229940072221 immunoglobulins Drugs 0.000 description 2
238000007901 in situ hybridization Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
229910052738 indium Inorganic materials 0.000 description 2
APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 2
206010022000 influenza Diseases 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
229910052740 iodine Inorganic materials 0.000 description 2
238000005304 joining Methods 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
201000000050 myeloid neoplasm Diseases 0.000 description 2
210000000822 natural killer cell Anatomy 0.000 description 2
201000001119 neuropathy Diseases 0.000 description 2
230000007823 neuropathy Effects 0.000 description 2
238000012261 overproduction Methods 0.000 description 2
230000003647 oxidation Effects 0.000 description 2
238000007254 oxidation reaction Methods 0.000 description 2
210000000496 pancreas Anatomy 0.000 description 2
210000001778 pluripotent stem cell Anatomy 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
229920000515 polycarbonate Polymers 0.000 description 2
239000004417 polycarbonate Substances 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
239000004800 polyvinyl chloride Substances 0.000 description 2
229920000915 polyvinyl chloride Polymers 0.000 description 2
230000001323 posttranslational effect Effects 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
230000000770 proinflammatory effect Effects 0.000 description 2
230000004952 protein activity Effects 0.000 description 2
238000002601 radiography Methods 0.000 description 2
238000003127 radioimmunoassay Methods 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
208000002574 reactive arthritis Diseases 0.000 description 2
230000010076 replication Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
230000003248 secreting effect Effects 0.000 description 2
230000028327 secretion Effects 0.000 description 2
230000036303 septic shock Effects 0.000 description 2
238000002864 sequence alignment Methods 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
208000017520 skin disease Diseases 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
230000000392 somatic effect Effects 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
208000006379 syphilis Diseases 0.000 description 2
230000008685 targeting Effects 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
206010043554 thrombocytopenia Diseases 0.000 description 2
210000001578 tight junction Anatomy 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
230000032258 transport Effects 0.000 description 2
230000000472 traumatic effect Effects 0.000 description 2
201000008827 tuberculosis Diseases 0.000 description 2
108010032276 tyrosyl-glutamyl-tyrosyl-glutamic acid Proteins 0.000 description 2
238000010798 ubiquitination Methods 0.000 description 2
230000034512 ubiquitination Effects 0.000 description 2
231100000397 ulcer Toxicity 0.000 description 2
238000005406 washing Methods 0.000 description 2
FMKJUUQOYOHLTF-OWOJBTEDSA-N (e)-4-azaniumylbut-2-enoate Chemical compound NC\C=C\C(O)=O FMKJUUQOYOHLTF-OWOJBTEDSA-N 0.000 description 1
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
YRIZYWQGELRKNT-UHFFFAOYSA-N 1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O YRIZYWQGELRKNT-UHFFFAOYSA-N 0.000 description 1
JKMPXGJJRMOELF-UHFFFAOYSA-N 1,3-thiazole-2,4,5-tricarboxylic acid Chemical compound OC(=O)C1=NC(C(O)=O)=C(C(O)=O)S1 JKMPXGJJRMOELF-UHFFFAOYSA-N 0.000 description 1
208000010543 22q11.2 deletion syndrome Diseases 0.000 description 1
TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
206010063409 Acarodermatitis Diseases 0.000 description 1
241000023308 Acca Species 0.000 description 1
241000589291 Acinetobacter Species 0.000 description 1
102100039819 Actin, alpha cardiac muscle 1 Human genes 0.000 description 1
241000606750 Actinobacillus Species 0.000 description 1
241000203809 Actinomycetales Species 0.000 description 1
102000005606 Activins Human genes 0.000 description 1
108010059616 Activins Proteins 0.000 description 1
208000026872 Addison Disease Diseases 0.000 description 1
241000701242 Adenoviridae Species 0.000 description 1
208000002004 Afibrinogenemia Diseases 0.000 description 1
208000008190 Agammaglobulinemia Diseases 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
VWEWCZSUWOEEFM-WDSKDSINSA-N Ala-Gly-Ala-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(O)=O VWEWCZSUWOEEFM-WDSKDSINSA-N 0.000 description 1
102100027211 Albumin Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
206010027654 Allergic conditions Diseases 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
208000004881 Amebiasis Diseases 0.000 description 1
206010001980 Amoebiasis Diseases 0.000 description 1
206010002198 Anaphylactic reaction Diseases 0.000 description 1
208000003343 Antiphospholipid Syndrome Diseases 0.000 description 1
108020004491 Antisense DNA Proteins 0.000 description 1
241000712892 Arenaviridae Species 0.000 description 1
201000002909 Aspergillosis Diseases 0.000 description 1
208000036641 Aspergillus infections Diseases 0.000 description 1
206010003591 Ataxia Diseases 0.000 description 1
208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 1
241001112741 Bacillaceae Species 0.000 description 1
241000193738 Bacillus anthracis Species 0.000 description 1
208000031729 Bacteremia Diseases 0.000 description 1
206010004053 Bacterial toxaemia Diseases 0.000 description 1
241000606126 Bacteroidaceae Species 0.000 description 1
208000023328 Basedow disease Diseases 0.000 description 1
241000702628 Birnaviridae Species 0.000 description 1
206010005098 Blastomycosis Diseases 0.000 description 1
241000588807 Bordetella Species 0.000 description 1
241000589968 Borrelia Species 0.000 description 1
208000003508 Botulism Diseases 0.000 description 1
206010006500 Brucellosis Diseases 0.000 description 1
208000011691 Burkitt lymphomas Diseases 0.000 description 1
125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000714198 Caliciviridae Species 0.000 description 1
241000589876 Campylobacter Species 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
206010007134 Candida infections Diseases 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
208000003732 Cat-scratch disease Diseases 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
206010007882 Cellulitis Diseases 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
201000006082 Chickenpox Diseases 0.000 description 1
241000606161 Chlamydia Species 0.000 description 1
241000606069 Chlamydiaceae Species 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
102100034330 Chromaffin granule amine transporter Human genes 0.000 description 1
206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
241001533399 Circoviridae Species 0.000 description 1
241000193403 Clostridium Species 0.000 description 1
206010053567 Coagulopathies Diseases 0.000 description 1
241000223205 Coccidioides immitis Species 0.000 description 1
208000003495 Coccidiosis Diseases 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
206010009944 Colon cancer Diseases 0.000 description 1
201000003874 Common Variable Immunodeficiency Diseases 0.000 description 1
102000000989 Complement System Proteins Human genes 0.000 description 1
108010069112 Complement System Proteins Proteins 0.000 description 1
108010062580 Concanavalin A Proteins 0.000 description 1
208000032170 Congenital Abnormalities Diseases 0.000 description 1
241000711573 Coronaviridae Species 0.000 description 1
241000186216 Corynebacterium Species 0.000 description 1
208000011231 Crohn disease Diseases 0.000 description 1
201000007336 Cryptococcosis Diseases 0.000 description 1
241000221204 Cryptococcus neoformans Species 0.000 description 1
208000008953 Cryptosporidiosis Diseases 0.000 description 1
206010011502 Cryptosporidiosis infection Diseases 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
208000020401 Depressive disease Diseases 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
208000000398 DiGeorge Syndrome Diseases 0.000 description 1
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
208000009514 Dourine Diseases 0.000 description 1
201000009084 Dysgammaglobulinemia Diseases 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
102100025137 Early activation antigen CD69 Human genes 0.000 description 1
206010014568 Empyema Diseases 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
206010014824 Endotoxic shock Diseases 0.000 description 1
241000588921 Enterobacteriaceae Species 0.000 description 1
241000186811 Erysipelothrix Species 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
206010016075 Factor I deficiency Diseases 0.000 description 1
206010016654 Fibrosis Diseases 0.000 description 1
241000710781 Flaviviridae Species 0.000 description 1
206010016952 Food poisoning Diseases 0.000 description 1
208000019331 Foodborne disease Diseases 0.000 description 1
241000233866 Fungi Species 0.000 description 1
206010017711 Gangrene Diseases 0.000 description 1
208000015872 Gaucher disease Diseases 0.000 description 1
206010018364 Glomerulonephritis Diseases 0.000 description 1
208000024869 Goodpasture syndrome Diseases 0.000 description 1
208000015023 Graves' disease Diseases 0.000 description 1
208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
208000031886 HIV Infections Diseases 0.000 description 1
208000037357 HIV infectious disease Diseases 0.000 description 1
206010061192 Haemorrhagic fever Diseases 0.000 description 1
206010019196 Head injury Diseases 0.000 description 1
241000589989 Helicobacter Species 0.000 description 1
208000006968 Helminthiasis Diseases 0.000 description 1
101710154606 Hemagglutinin Proteins 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
241000700739 Hepadnaviridae Species 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
230000010556 Heparin Binding Activity Effects 0.000 description 1
206010019663 Hepatic failure Diseases 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
208000007514 Herpes zoster Diseases 0.000 description 1
241000700586 Herpesviridae Species 0.000 description 1
102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 1
101000959247 Homo sapiens Actin, alpha cardiac muscle 1 Proteins 0.000 description 1
101100005713 Homo sapiens CD4 gene Proteins 0.000 description 1
101000641221 Homo sapiens Chromaffin granule amine transporter Proteins 0.000 description 1
101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 1
101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
101000957437 Homo sapiens Mitochondrial carnitine/acylcarnitine carrier protein Proteins 0.000 description 1
101001128634 Homo sapiens NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial Proteins 0.000 description 1
206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 description 1
241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
208000023105 Huntington disease Diseases 0.000 description 1
208000019758 Hypergammaglobulinemia Diseases 0.000 description 1
206010020983 Hypogammaglobulinaemia Diseases 0.000 description 1
102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
208000007746 Immunologic Deficiency Syndromes Diseases 0.000 description 1
206010021531 Impetigo Diseases 0.000 description 1
206010061216 Infarction Diseases 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
206010023076 Isosporiasis Diseases 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
208000004023 Legionellosis Diseases 0.000 description 1
208000004554 Leishmaniasis Diseases 0.000 description 1
241000713666 Lentivirus Species 0.000 description 1
206010024229 Leprosy Diseases 0.000 description 1
206010024238 Leptospirosis Diseases 0.000 description 1
208000000706 Leukocyte-Adhesion Deficiency Syndrome Diseases 0.000 description 1
241000186781 Listeria Species 0.000 description 1
208000004852 Lung Injury Diseases 0.000 description 1
208000019693 Lung disease Diseases 0.000 description 1
FSNCEEGOMTYXKY-JTQLQIEISA-N Lycoperodine 1 Natural products N1C2=CC=CC=C2C2=C1CN[C@H](C(=O)O)C2 FSNCEEGOMTYXKY-JTQLQIEISA-N 0.000 description 1
206010025327 Lymphopenia Diseases 0.000 description 1
208000030289 Lymphoproliferative disease Diseases 0.000 description 1
201000005505 Measles Diseases 0.000 description 1
206010049567 Miller Fisher syndrome Diseases 0.000 description 1
102100038738 Mitochondrial carnitine/acylcarnitine carrier protein Human genes 0.000 description 1
241000712045 Morbillivirus Species 0.000 description 1
208000001089 Multiple system atrophy Diseases 0.000 description 1
208000005647 Mumps Diseases 0.000 description 1
101000975477 Mus musculus Keratin, type I cytoskeletal 12 Proteins 0.000 description 1
241000186359 Mycobacterium Species 0.000 description 1
241000204003 Mycoplasmatales Species 0.000 description 1
125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
102100032194 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial Human genes 0.000 description 1
241000588656 Neisseriaceae Species 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
206010029240 Neuritis Diseases 0.000 description 1
102100039019 Nuclear receptor subfamily 0 group B member 1 Human genes 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
241000712464 Orthomyxoviridae Species 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
208000001132 Osteoporosis Diseases 0.000 description 1
101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241000711504 Paramyxoviridae Species 0.000 description 1
208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
208000002774 Paraproteinemias Diseases 0.000 description 1
208000026681 Paratuberculosis Diseases 0.000 description 1
206010033971 Paratyphoid fever Diseases 0.000 description 1
208000018737 Parkinson disease Diseases 0.000 description 1
206010034016 Paronychia Diseases 0.000 description 1
241000029132 Paronychia Species 0.000 description 1
241000701945 Parvoviridae Species 0.000 description 1
241000606860 Pasteurella Species 0.000 description 1
206010034277 Pemphigoid Diseases 0.000 description 1
241000721454 Pemphigus Species 0.000 description 1
241000150350 Peribunyaviridae Species 0.000 description 1
208000010886 Peripheral nerve injury Diseases 0.000 description 1
201000005702 Pertussis Diseases 0.000 description 1
208000004666 Phagocyte Bactericidal Dysfunction Diseases 0.000 description 1
241000709664 Picornaviridae Species 0.000 description 1
101100271190 Plasmodium falciparum (isolate 3D7) ATAT gene Proteins 0.000 description 1
241000232219 Platanista Species 0.000 description 1
208000000474 Poliomyelitis Diseases 0.000 description 1
208000025237 Polyendocrinopathy Diseases 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
241000700625 Poxviridae Species 0.000 description 1
208000002787 Pregnancy Complications Diseases 0.000 description 1
208000004210 Pressure Ulcer Diseases 0.000 description 1
208000031482 Prosthesis-Related Infections Diseases 0.000 description 1
101710176177 Protein A56 Proteins 0.000 description 1
102100029812 Protein S100-A12 Human genes 0.000 description 1
101710110949 Protein S100-A12 Proteins 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
206010037742 Rabies Diseases 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
241000702247 Reoviridae Species 0.000 description 1
206010057190 Respiratory tract infections Diseases 0.000 description 1
241000712907 Retroviridae Species 0.000 description 1
241000711931 Rhabdoviridae Species 0.000 description 1
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
241000606683 Rickettsiaceae Species 0.000 description 1
241000702670 Rotavirus Species 0.000 description 1
241000710801 Rubivirus Species 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
241000447727 Scabies Species 0.000 description 1
206010039587 Scarlet Fever Diseases 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
206010053879 Sepsis syndrome Diseases 0.000 description 1
241000607720 Serratia Species 0.000 description 1
208000009359 Sezary Syndrome Diseases 0.000 description 1
208000021388 Sezary disease Diseases 0.000 description 1
208000009106 Shy-Drager Syndrome Diseases 0.000 description 1
108010016797 Sickle Hemoglobin Proteins 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
208000029033 Spinal Cord disease Diseases 0.000 description 1
241000256248 Spodoptera Species 0.000 description 1
206010072148 Stiff-Person syndrome Diseases 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 1
206010043189 Telangiectasia Diseases 0.000 description 1
208000000491 Tendinopathy Diseases 0.000 description 1
206010043255 Tendonitis Diseases 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
206010043376 Tetanus Diseases 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
208000001117 Theileriasis Diseases 0.000 description 1
108010022394 Threonine synthase Proteins 0.000 description 1
241000710924 Togaviridae Species 0.000 description 1
208000013222 Toxemia Diseases 0.000 description 1
108020004566 Transfer RNA Proteins 0.000 description 1
206010069363 Traumatic lung injury Diseases 0.000 description 1
241000224526 Trichomonas Species 0.000 description 1
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
102100040247 Tumor necrosis factor Human genes 0.000 description 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
208000037386 Typhoid Diseases 0.000 description 1
206010046851 Uveitis Diseases 0.000 description 1
206010046865 Vaccinia virus infection Diseases 0.000 description 1
206010046980 Varicella Diseases 0.000 description 1
241000700647 Variola virus Species 0.000 description 1
206010054880 Vascular insufficiency Diseases 0.000 description 1
206010058874 Viraemia Diseases 0.000 description 1
208000033559 Waldenström macroglobulinemia Diseases 0.000 description 1
206010048038 Wound infection Diseases 0.000 description 1
241000607734 Yersinia <bacteria> Species 0.000 description 1
SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 1
210000001015 abdomen Anatomy 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000000488 activin Substances 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
108700010877 adenoviridae proteins Proteins 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
230000001919 adrenal effect Effects 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
238000012867 alanine scanning Methods 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000000172 allergic effect Effects 0.000 description 1
230000009435 amidation Effects 0.000 description 1
238000007112 amidation reaction Methods 0.000 description 1
150000001408 amides Chemical group 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
238000012870 ammonium sulfate precipitation Methods 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
230000036783 anaphylactic response Effects 0.000 description 1
208000003455 anaphylaxis Diseases 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
230000033115 angiogenesis Effects 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
238000005571 anion exchange chromatography Methods 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000003172 anti-dna Effects 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
230000030741 antigen processing and presentation Effects 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
239000003816 antisense DNA Substances 0.000 description 1
230000036528 appetite Effects 0.000 description 1
235000019789 appetite Nutrition 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
230000010516 arginylation Effects 0.000 description 1
238000010420 art technique Methods 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
201000008680 babesiosis Diseases 0.000 description 1
108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 1
229910052788 barium Inorganic materials 0.000 description 1
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
208000015294 blood coagulation disease Diseases 0.000 description 1
201000001383 blood group incompatibility Diseases 0.000 description 1
210000001772 blood platelet Anatomy 0.000 description 1
208000014759 blood platelet disease Diseases 0.000 description 1
208000016363 blood protein disease Diseases 0.000 description 1
238000006664 bond formation reaction Methods 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
208000000594 bullous pemphigoid Diseases 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
229910052792 caesium Inorganic materials 0.000 description 1
TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
244000309466 calf Species 0.000 description 1
201000003984 candidiasis Diseases 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
208000003295 carpal tunnel syndrome Diseases 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
238000005277 cation exchange chromatography Methods 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
208000026106 cerebrovascular disease Diseases 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
230000008711 chromosomal rearrangement Effects 0.000 description 1
238000003200 chromosome mapping Methods 0.000 description 1
208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
230000027288 circadian rhythm Effects 0.000 description 1
238000010367 cloning Methods 0.000 description 1
201000003486 coccidioidomycosis Diseases 0.000 description 1
230000001149 cognitive effect Effects 0.000 description 1
206010009887 colitis Diseases 0.000 description 1
201000010897 colon adenocarcinoma Diseases 0.000 description 1
201000011024 colonic benign neoplasm Diseases 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
210000001100 crypt cell Anatomy 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
108091092330 cytoplasmic RNA Proteins 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000017858 demethylation Effects 0.000 description 1
238000010520 demethylation reaction Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
229910052805 deuterium Inorganic materials 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
201000004587 dientamoebiasis Diseases 0.000 description 1
230000029087 digestion Effects 0.000 description 1
210000002249 digestive system Anatomy 0.000 description 1
102000004419 dihydrofolate reductase Human genes 0.000 description 1
206010013023 diphtheria Diseases 0.000 description 1
BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000007876 drug discovery Methods 0.000 description 1
230000009982 effect on human Effects 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
238000000804 electron spin resonance spectroscopy Methods 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
206010014599 encephalitis Diseases 0.000 description 1
206010014665 endocarditis Diseases 0.000 description 1
210000003372 endocrine gland Anatomy 0.000 description 1
206010014801 endophthalmitis Diseases 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
210000003038 endothelium Anatomy 0.000 description 1
210000003989 endothelium vascular Anatomy 0.000 description 1
231100000284 endotoxic Toxicity 0.000 description 1
210000003979 eosinophil Anatomy 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
230000028023 exocytosis Effects 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
208000030533 eye disease Diseases 0.000 description 1
230000004761 fibrosis Effects 0.000 description 1
239000012847 fine chemical Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000001506 fluorescence spectroscopy Methods 0.000 description 1
239000011888 foil Substances 0.000 description 1
235000013373 food additive Nutrition 0.000 description 1
239000002778 food additive Substances 0.000 description 1
235000019249 food preservative Nutrition 0.000 description 1
239000005452 food preservative Substances 0.000 description 1
230000037433 frameshift Effects 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
230000006251 gamma-carboxylation Effects 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
208000007565 gingivitis Diseases 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
150000003278 haem Chemical group 0.000 description 1
210000004209 hair Anatomy 0.000 description 1
230000037308 hair color Effects 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
210000003128 head Anatomy 0.000 description 1
230000035876 healing Effects 0.000 description 1
108010049074 hemoglobin B Proteins 0.000 description 1
201000001505 hemoglobinuria Diseases 0.000 description 1
208000007475 hemolytic anemia Diseases 0.000 description 1
230000011132 hemopoiesis Effects 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
238000012188 high-throughput screening assay Methods 0.000 description 1
210000003630 histaminocyte Anatomy 0.000 description 1
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
201000008298 histiocytosis Diseases 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
210000004754 hybrid cell Anatomy 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000012872 hydroxylapatite chromatography Methods 0.000 description 1
230000033444 hydroxylation Effects 0.000 description 1
238000005805 hydroxylation reaction Methods 0.000 description 1
230000009610 hypersensitivity Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
229940127121 immunoconjugate Drugs 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
230000036046 immunoreaction Effects 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
238000011503 in vivo imaging Methods 0.000 description 1
208000033065 inborn errors of immunity Diseases 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000007574 infarction Effects 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
230000004968 inflammatory condition Effects 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
208000028774 intestinal disease Diseases 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
210000002490 intestinal epithelial cell Anatomy 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
230000026045 iodination Effects 0.000 description 1
238000006192 iodination reaction Methods 0.000 description 1
239000011630 iodine Substances 0.000 description 1
208000012947 ischemia reperfusion injury Diseases 0.000 description 1
239000012948 isocyanate Substances 0.000 description 1
229960000318 kanamycin Drugs 0.000 description 1
229930027917 kanamycin Natural products 0.000 description 1
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
206010023332 keratitis Diseases 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
238000011813 knockout mouse model Methods 0.000 description 1
238000001499 laser induced fluorescence spectroscopy Methods 0.000 description 1
239000002523 lectin Substances 0.000 description 1
231100000225 lethality Toxicity 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
208000019423 liver disease Diseases 0.000 description 1
208000007903 liver failure Diseases 0.000 description 1
231100000835 liver failure Toxicity 0.000 description 1
231100000515 lung injury Toxicity 0.000 description 1
206010025135 lupus erythematosus Diseases 0.000 description 1
210000004324 lymphatic system Anatomy 0.000 description 1
231100001023 lymphopenia Toxicity 0.000 description 1
201000000564 macroglobulinemia Diseases 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
238000013160 medical therapy Methods 0.000 description 1
239000002609 medium Substances 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
230000006996 mental state Effects 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000031864 metaphase Effects 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000001483 mobilizing effect Effects 0.000 description 1
238000001823 molecular biology technique Methods 0.000 description 1
239000002808 molecular sieve Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
208000010805 mumps infectious disease Diseases 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
206010028417 myasthenia gravis Diseases 0.000 description 1
201000005962 mycosis fungoides Diseases 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
230000007498 myristoylation Effects 0.000 description 1
201000009240 nasopharyngitis Diseases 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
239000006225 natural substrate Substances 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
230000009826 neoplastic cell growth Effects 0.000 description 1
201000008383 nephritis Diseases 0.000 description 1
210000000944 nerve tissue Anatomy 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229940046166 oligodeoxynucleotide Drugs 0.000 description 1
210000004789 organ system Anatomy 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
244000045947 parasite Species 0.000 description 1
230000003071 parasitic effect Effects 0.000 description 1
208000014837 parasitic helminthiasis infectious disease Diseases 0.000 description 1
230000000849 parathyroid Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000007170 pathology Effects 0.000 description 1
230000006320 pegylation Effects 0.000 description 1
208000028169 periodontal disease Diseases 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
208000027232 peripheral nervous system disease Diseases 0.000 description 1
208000033808 peripheral neuropathy Diseases 0.000 description 1
210000004303 peritoneum Anatomy 0.000 description 1
230000002688 persistence Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
101150009573 phoA gene Proteins 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
229940080469 phosphocellulose Drugs 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
230000019612 pigmentation Effects 0.000 description 1
230000001817 pituitary effect Effects 0.000 description 1
210000002381 plasma Anatomy 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
102000054765 polymorphisms of proteins Human genes 0.000 description 1
229920000379 polypropylene carbonate Polymers 0.000 description 1
239000005373 porous glass Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
208000012113 pregnancy disease Diseases 0.000 description 1
230000013823 prenylation Effects 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
208000011354 prosthesis-related infectious disease Diseases 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
229940043131 pyroglutamate Drugs 0.000 description 1
230000006340 racemization Effects 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000000163 radioactive labelling Methods 0.000 description 1
239000000700 radioactive tracer Substances 0.000 description 1
238000002708 random mutagenesis Methods 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
208000020029 respiratory tract infectious disease Diseases 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
201000003068 rheumatic fever Diseases 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
238000007363 ring formation reaction Methods 0.000 description 1
201000005404 rubella Diseases 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
201000000306 sarcoidosis Diseases 0.000 description 1
208000005687 scabies Diseases 0.000 description 1
230000037390 scarring Effects 0.000 description 1
210000004739 secretory vesicle Anatomy 0.000 description 1
210000000582 semen Anatomy 0.000 description 1
208000002491 severe combined immunodeficiency Diseases 0.000 description 1
230000035939 shock Effects 0.000 description 1
230000011664 signaling Effects 0.000 description 1
239000002356 single layer Substances 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
230000019635 sulfation Effects 0.000 description 1
238000005670 sulfation reaction Methods 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
239000013589 supplement Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
201000000596 systemic lupus erythematosus Diseases 0.000 description 1
208000009056 telangiectasis Diseases 0.000 description 1
201000004415 tendinitis Diseases 0.000 description 1
210000001550 testis Anatomy 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
229940126585 therapeutic drug Drugs 0.000 description 1
210000000115 thoracic cavity Anatomy 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
210000001685 thyroid gland Anatomy 0.000 description 1
206010043778 thyroiditis Diseases 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
230000005945 translocation Effects 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
229910052722 tritium Inorganic materials 0.000 description 1
208000008776 trombiculiasis Diseases 0.000 description 1
201000002311 trypanosomiasis Diseases 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
201000008297 typhoid fever Diseases 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
208000019206 urinary tract infection Diseases 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
208000007089 vaccinia Diseases 0.000 description 1
230000002792 vascular Effects 0.000 description 1
208000023577 vascular insufficiency disease Diseases 0.000 description 1
238000012795 verification Methods 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
238000001262 western blot Methods 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Diabetes (AREA)
Neurology (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Virology (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Tropical Medicine & Parasitology (AREA)
Physical Education & Sports Medicine (AREA)
Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Gastroenterology & Hepatology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)

AU55933/00A 1999-06-01 2000-06-01 Modulation of gene expression in gastrointestinal inflammation Abandoned AU5593300A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US13705899P	1999-06-01	1999-06-01
US60137058		1999-06-01
PCT/US2000/015191 WO2000073324A2 (fr)	1999-06-01	2000-06-01	Modulation d'expression genique dans une inflammation gastro-intestinale

Publications (1)

Publication Number	Publication Date
AU5593300A true AU5593300A (en)	2000-12-18

Family

ID=22475654

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU55933/00A Abandoned AU5593300A (en)	1999-06-01	2000-06-01	Modulation of gene expression in gastrointestinal inflammation

Country Status (7)

Country	Link
EP (1)	EP1181385A4 (fr)
JP (1)	JP2003501017A (fr)
AU (1)	AU5593300A (fr)
CA (1)	CA2375855A1 (fr)
HK (1)	HK1044779A1 (fr)
MX (1)	MXPA01012381A (fr)
WO (1)	WO2000073324A2 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5322687A (en) *	1993-07-29	1994-06-21	Ecogen Inc.	Bacillus thuringiensis cryet4 and cryet5 toxin genes and proteins toxic to lepidopteran insects

2000
- 2000-06-01 JP JP2001500649A patent/JP2003501017A/ja active Pending
- 2000-06-01 CA CA002375855A patent/CA2375855A1/fr not_active Abandoned
- 2000-06-01 HK HK02106340.2A patent/HK1044779A1/zh unknown
- 2000-06-01 AU AU55933/00A patent/AU5593300A/en not_active Abandoned
- 2000-06-01 WO PCT/US2000/015191 patent/WO2000073324A2/fr not_active Ceased
- 2000-06-01 MX MXPA01012381A patent/MXPA01012381A/es unknown
- 2000-06-01 EP EP00941187A patent/EP1181385A4/fr not_active Withdrawn

Also Published As

Publication number	Publication date
WO2000073324A3 (fr)	2001-07-19
WO2000073324A2 (fr)	2000-12-07
WO2000073324A9 (fr)	2001-08-09
JP2003501017A (ja)	2003-01-14
EP1181385A4 (fr)	2003-03-19
HK1044779A1 (zh)	2002-11-01
MXPA01012381A (es)	2002-07-22
EP1181385A2 (fr)	2002-02-27
CA2375855A1 (fr)	2000-12-07

Publication	Publication Date	Title
JP2002521055A (ja)	2002-07-16	９８個のヒト分泌タンパク質
CN1150804A (zh)	1997-05-28	成纤维细胞生长因子-10
CA2270156A1 (fr)	1998-05-22	Proteines humaines specifiques de tumeur du sein
JP2003523190A (ja)	2003-08-05	新規化合物
US20030166914A1 (en)	2003-09-04	CD33-like protein
CN101440128A (zh)	2009-05-27	人脑胶质瘤中差异表达的蛋白及其用途
JP2001519179A (ja)	2001-10-23	５３個のヒト分泌タンパク質
JP4190291B2 (ja)	2008-12-03	癌細胞の増殖を調節するのに有用なポリヌクレオチド
JP2003506017A (ja)	2003-02-18	セリパンクリン
JP2002532054A (ja)	2002-10-02	２９個のヒト分泌タンパク質
AU5593300A (en)	2000-12-18	Modulation of gene expression in gastrointestinal inflammation
WO2000077166A2 (fr)	2000-12-21	Expression genique modulee dans des inflammations gastro-intestinales
JPH1175872A (ja)	1999-03-23	新規化合物
WO2001029179A2 (fr)	2001-04-26	Regulation de l'expression genetique par des neuromodulateurs
WO2002031114A2 (fr)	2002-04-18	Expression genique module dans l'ileite
WO2000028026A2 (fr)	2000-05-18	Expression genique modulee par l'administration ou l'etat de manque d'opiaces
WO1997043413A1 (fr)	1997-11-20	Element de chaine lourde d'homologue humain de la famille kinesine
MXPA02004241A (es)	2002-10-17	Regulacion de la expresion de genes por agentes neurolepticos.
WO2002042420A2 (fr)	2002-05-30	Modulation de l'expression de genes lors de l'hyperplasie de l'intima de l'artere carotide
WO2001012647A1 (fr)	2001-02-22	Expression genique modulee en tumorigenese de l'ataxie-telangiectasie
WO2003091390A2 (fr)	2003-11-06	Regulation de l'expression genique par des neuromodulateurs et identification d'une nouvelle proteine induite par le ngf denommee pincher
US7270980B2 (en)	2007-09-18	Compounds for immunodiagnosis of prostate cancer and methods for their use
WO2000061738A2 (fr)	2000-10-19	Regulation differentielle de l'expression genique dans une transformation oncogene
WO2002031116A2 (fr)	2002-04-18	Expression genique modulee dans des maladies enteriques inflammatoires spontanees
JP2003523758A (ja)	2003-08-12	新規転写因子ｃａｒｐ−２